TL;DR: Vbot is shipping robotic dogs — 500 units now, 2,500 per month by June. Wandercraft raised $75M to build medical exoskeletons in France. Neura Robotics hit a €1 billion valuation in Germany. And Europe is pushing robotics sovereignty hard.
🔥 Top Story: Vbot Ships Robotic Dogs and Plans Humanoids
Chinese embodied AI startup Vbot raised about $73 million in a Pre-A round. The money will expand production and develop full-size humanoid robots.
Here’s the real story: Vbot is already shipping. Its first product — a robotic dog — has an initial run of 500 units. The company plans to hit 2,500 units per month by June. That’s a 5x jump in weeks, not years.
The round was co-led by Oriental Fortune Capital, Huatai Zijin Investment, and Fosun RZ Capital. SAIC Motor’s Shangqi Capital also joined.
So what?: Most humanoid startups are still in the lab. Vbot is shipping a product, scaling production, and planning humanoids in parallel. That’s a different playbook.
My take: The robotic dog is a smart stepping stone. It’s simpler than a humanoid, has real consumer demand, and generates revenue and manufacturing experience while the humanoid tech matures. Think of it as Tesla selling the Roadster before the Model S.
Credibility: 🟡 Reported by PanDaily
Source: The AI Insider
⚡ Quick Hits
Wandercraft Raises $75M Series D for Medical Exoskeletons
Renault Group and Bpifrance-managed PSIM co-led the round. Wandercraft builds medical-grade self-balancing exoskeletons — Atalante and a next-generation Personal Exoskeleton. The company is now extending into AI-powered humanoid robotics. Total funding: over $200M.
Why it matters: This is the European robotics template — medical certification first (CE marking, ISO 13485), then industrial expansion. France’s France 2030 plan earmarked €7.5B for AI and robotics. Wandercraft is drawing from that well.
Source: Peony.ink
Neura Robotics Hits €1B Valuation
Neura Robotics raised €120M in a Series B led by Lingotto Investment Management with HV Capital and Volvo Cars Tech Fund. The company ships MAiRA, a cognitive industrial robot, and 4NE-1, a humanoid platform for German manufacturing.
Why it matters: Neura had paying industrial pilots with German Mittelstand customers before the raise. That’s the German robotics playbook: prove it works in a factory, then raise. Volvo’s strategic investment signals automotive OEM interest in next-gen assembly.
Source: Peony.ink
ROBOTERA — More Details Emerge
The full investor list for ROBOTERA’s $200M+ round is out: HSG, IDG Capital, Hillhouse, CICC Capital, China Unicom funds, KENGIC, Dongfeng Asset, ICBC Capital, Jingming Capital, SparkEdge, Luxin, Unite Pioneers, Longqi Investment. Existing investors Tsinghua Holding and Horizon increased their stakes.
Why it matters: This is not a small club. It’s a who’s-who of Chinese industrial and financial capital. The fact that existing investors doubled down is a stronger signal than new money alone.
Source: The AI Insider
🌍 Europe’s Robotics Sovereignty Push
Three major European robotics rounds in 2024-2026 share a pattern:
| Company | Country | Round | Sovereignty Angle | |---------| Wandercraft | France | $75M Series D | France 2030 / Bpifrance | | Neura Robotics | Germany | €120M Series B | Bayern Innovativ / Volvo strategic | | Genesis AI | France | $105M seed | French national champion |
What’s happening: Europe is building its own robotics supply chain, separate from the US and China. France and Germany are using state funds and strategic OEM investments to anchor domestic companies. The EU AI Act — even with its recent delay — creates a regulatory moat that favors EU-compliant companies.
My take: This is smart industrial policy. The US has venture capital. China has scale and manufacturing. Europe has regulation and strategic capital. Each is building a different kind of moat. The question is which one wins in the long run.
🔥 Hot Take
The humanoid race is splitting into three tracks:
- China: Scale fast, ship units, learn in the field (ROBOTERA, Vbot, Unitree)
- US: Big tech bets, video demos, long-term R&D (Tesla, Figure, Boston Dynamics)
- Europe: Medical and industrial certification, strategic sovereignty (Wandercraft, Neura, Genesis)
Each track has a different definition of “winning.” China measures units shipped. The US measures model capability. Europe measures regulatory approval and strategic independence.
All three can be right at the same time. But they won’t compete directly — they’ll dominate different markets.
Key Takeaways
- Shipping beats demoing: Vbot’s 500→2,500 unit ramp is the real signal. Most competitors are still at zero.
- Europe is not sitting out: France and Germany are using state funds to build national robotics champions.
- Medical → industrial → humanoid: Wandercraft’s exoskeleton-to-humanoid path is a template for regulated markets.
For informational purposes only.
Frequently Asked Questions
What is this topic?
[Provide a direct answer in 40-60 words that can stand alone as a complete response.]
How does this topic work?
[Explain the mechanism or process clearly, using numbered steps if applicable.]
What are the main risks or challenges?
[Provide a balanced assessment of limitations and obstacles.]
GEO optimized: 2026-05-23